# Study Design of the Diacerein in Patients With Covid-19

> **NCT05226754** · PHASE2 · UNKNOWN · sponsor: **University of Campinas, Brazil** · enrollment: 40 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Diacerein
- **DRUG:** placebo capsules

## Key facts

- **NCT ID:** NCT05226754
- **Lead sponsor:** University of Campinas, Brazil
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-04-01
- **Primary completion:** 2023-06-30
- **Final completion:** 2023-07-08
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-08-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05226754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05226754, "Study Design of the Diacerein in Patients With Covid-19". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05226754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*